October 1, 2024 Investor Beware: Port Strike Puts Key Stocks And Sectors At Risk
September 30, 2024 Market Movers: Jobs Report and Key Earnings in Focus
September 19, 2024 Federal Reserve’s Aggressive Move Hints At Bold Economic Strategy
The Biggest Problem With Nvidia’s Stock That Everyone Is Missing
Amazon Is Firing On All Cylinders
Tesla’s Robotaxi: Hype Meets Reality – Maintain Hold
Tesla: The 10/10 Moment Of Truth For Robotaxis
October 3, 2024 Your Path to Profits: The Best Trading Platforms for New Traders
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
GoodRx Holdings (GDRX) stock forecast for 2024
Updated: October 12, 2024 (15:36)
Sector: HealthcareThe share price of GoodRx Holdings, Inc. (GDRX) now
50/200 Day Moving Average: $7.45 / $7.28
This figure corresponds to the Average Price over the previous 50/200 days. For GoodRx Holdings stocks, the 50-day moving average is the resistance level today.
For GoodRx Holdings stocks, the 200-day moving average is the resistance level today.
Are you interested in GoodRx Holdings, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the GoodRx Holdings stock price in 2024. How much will one GoodRx Holdings share be worth in 2024? Is it worth taking profit / loss on GDRX stock now or waiting? What are analysts' forecasts for GoodRx Holdings stock?
We forecast GoodRx Holdings stock performance using neural networks based on historical data on GDRX stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
GoodRx Holdings, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for GoodRx Holdings analysts is $9.44. Today 200 Day Moving Average is the resistance level (7.28 $). 50 Day Moving Average is the resistance level (7.45 $).
Historical and forecast chart of GoodRx Holdings, Inc. stock
The chart below shows the historical price of GoodRx Holdings stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the GDRX stock price can be found in the table below.
GoodRx Holdings IPO will take place on September 22, 2020. The company is a developer of a platform that collects various data from 70 thousand pharmacies and compares drug prices to find cheaper ones. The placement underwriters are Morgan Stanley, Goldman Sachs, J.P. Morgan and Barclays.
ABOUT IPO, SHAREHOLDERS AND PURCHASE OF GOODRX
Among the company’s shareholders are Silver Lake with a 35.3% stake (33.8% after the IPO), Francisco Partners with a 23.7% stake (22.1% after the IPO), Spectrum with a 15.4% stake (12 , 5% after the IPO) and Idea Men with a share of 17.9 %% (15.6% after the IPO). Silver Lake will IPO $ 100 million in Class A shares in a private placement that will take place concurrently with the IPO. In total, the company is placing 34.615 million shares, of which 23.4 million shares are sold by the company itself and 11.192 million – by the company’s shareholders. Throughout its history, the company has made two acquisitions – Iodine (a company that helps patients select the right drugs) in January 2017 and HeyDoctor (a telemedicine provider) in September 2019.
GoodRx Holdings (GDRX) Forecast for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Nov | 7.19 | 6.96 | 7.65 | 9.03 % |
| Dec | 8.04 | 7.39 | 8.54 | 13.46 % |
GoodRx Holdings information and performance
233 WILSHIRE BLVD., SUITE 990, SANTA MONICA, CA, US
Market capitalization of the GoodRx Holdings, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GDRX shares in the company outstanding by the market price of one share.
EBITDA of GoodRx Holdings is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
GoodRx Holdings price target for 2024 by month
Target values for the price of one GoodRx Holdings share for Nov 2024.
In Nov, the Positive dynamics for GoodRx Holdings, Inc. shares will prevail with possible monthly volatility of 9.026% volatility is expected.
Pessimistic target level: 6.96
Optimistic target level: 7.65
Target values for the price of one GoodRx Holdings share for Dec 2024.
In Dec, the Positive dynamics for GoodRx Holdings, Inc. shares will prevail with possible monthly volatility of 13.457% volatility is expected.
Pessimistic target level: 7.39
Optimistic target level: 8.54
Related stocks from Healthcare sector
